These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15837534)

  • 21. The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory.
    Wright JW; Harding JW
    Prog Neurobiol; 2004 Mar; 72(4):263-93. PubMed ID: 15142685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis.
    Ji Z; Huang C; Liang C; Chen B; Chen S; Sun W
    Cell Mol Immunol; 2005 Apr; 2(2):150-4. PubMed ID: 16191423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Angiotensin II receptors during pregnancy induces malformations in developing rat kidney.
    Sánchez SI; Seltzer AM; Fuentes LB; Forneris ML; Ciuffo GM
    Eur J Pharmacol; 2008 Jun; 588(1):114-23. PubMed ID: 18495111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinical approach in regression of glomerulosclerosis.
    Stoian M; Radulian G; Chiţac D; Simion E; Stoica V
    Rom J Intern Med; 2007; 45(2):215-8. PubMed ID: 18333378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renin inhibition in hypertension.
    Gradman AH; Kad R
    J Am Coll Cardiol; 2008 Feb; 51(5):519-28. PubMed ID: 18237679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin IV in the central nervous system.
    von Bohlen und Halbach O
    Cell Tissue Res; 2003 Jan; 311(1):1-9. PubMed ID: 12483279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CNS renin-angiotensin system.
    von Bohlen und Halbach O; Albrecht D
    Cell Tissue Res; 2006 Nov; 326(2):599-616. PubMed ID: 16555051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II increases tissue-specific inhibitor of metalloproteinase-2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressure-independent effect.
    Castoldi G; di Gioia CR; Travaglini C; Busca G; Redaelli S; Bombardi C; Stella A
    Clin Exp Pharmacol Physiol; 2007 Mar; 34(3):205-9. PubMed ID: 17250640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
    Naelten G; Liu KL; Chapuis B; Lo M
    Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACE inhibitor and AT1 antagonist stimulate duodenal HCO3- secretion mediated by a common pathway - involvement of PG, NO and bradykinin.
    Aihara E; Kagawa S; Hayashi M; Takeuchi K
    J Physiol Pharmacol; 2005 Sep; 56(3):391-406. PubMed ID: 16204762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation.
    Plante E; Lachance D; Beaudoin J; Champetier S; Roussel E; Arsenault M; Couet J
    Circ Heart Fail; 2009 Jan; 2(1):25-32. PubMed ID: 19808312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
    Björck S; Aurell M
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Ang II and renal sympathetic nerve influence dopamine-and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats.
    Abdulla MH; Sattar MA; Abdullah NA; Hazim AI; Anand Swarup KR; Rathore HA; Khan MA; Johns EJ
    Auton Autacoid Pharmacol; 2008 Oct; 28(4):95-101. PubMed ID: 18778332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function.
    Qian C; Schoemaker RG; van Gilst WH; Roks AJ
    Clin Sci (Lond); 2009 Feb; 116(4):301-14. PubMed ID: 19138171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular changes by long-term inhibition of the renin-angiotensin system in aging.
    Inserra F; Romano L; Ercole L; de Cavanagh EM; Ferder L
    Hypertension; 1995 Mar; 25(3):437-42. PubMed ID: 7875769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aging and the kidney.
    Perico N; Remuzzi G; Benigni A
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):312-7. PubMed ID: 21358327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.